These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 23560583)

  • 1. Residual newborn screening samples for research: parental information needs for decision-making.
    Rothwell E; Clark L; Anderson R; Botkin JR
    J Spec Pediatr Nurs; 2013 Apr; 18(2):115-22. PubMed ID: 23560583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public attitudes regarding the use of residual newborn screening specimens for research.
    Botkin JR; Rothwell E; Anderson R; Stark L; Goldenberg A; Lewis M; Burbank M; Wong B
    Pediatrics; 2012 Feb; 129(2):231-8. PubMed ID: 22250018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parental Consent for the Use of Residual Newborn Screening Bloodspots: Respecting Individual Liberty vs Ensuring Public Health.
    Bayefsky MJ; Saylor KW; Berkman BE
    JAMA; 2015 Jul; 314(1):21-2. PubMed ID: 26053685
    [No Abstract]   [Full Text] [Related]  

  • 4. Lessons from the residual newborn screening dried blood sample litigation.
    Lewis MH
    J Law Med Ethics; 2015; 43 Suppl 1():32-5. PubMed ID: 25846160
    [No Abstract]   [Full Text] [Related]  

  • 5. State laws regarding the retention and use of residual newborn screening blood samples.
    Lewis MH; Goldenberg A; Anderson R; Rothwell E; Botkin J
    Pediatrics; 2011 Apr; 127(4):703-12. PubMed ID: 21444595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newborn dried blood spot screening: residual specimen storage issues.
    Therrell BL; Hannon WH
    Pediatrics; 2012 Feb; 129(2):365-6. PubMed ID: 22250020
    [No Abstract]   [Full Text] [Related]  

  • 7. What parents want to know about the storage and use of residual newborn bloodspots.
    Botkin JR; Rothwell E; Anderson RA; Goldenberg A; Kuppermann M; Dolan SM; Rose NC; Stark L
    Am J Med Genet A; 2014 Nov; 164A(11):2739-44. PubMed ID: 25131714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Influence of Education on Public Trust and Consent Preferences With Residual Newborn Screening Dried Blood spots.
    Rothwell E; Wong B; Anderson RA; Botkin JR
    J Empir Res Hum Res Ethics; 2016 Jul; 11(3):231-6. PubMed ID: 27387457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Attitudes about the use of newborn dried blood spots for research: a survey of underrepresented parents.
    Hendrix KS; Meslin EM; Carroll AE; Downs SM
    Acad Pediatr; 2013; 13(5):451-7. PubMed ID: 24011748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Talking with parents before newborn screening.
    Clayton EW
    J Pediatr; 2005 Sep; 147(3 Suppl):S26-9. PubMed ID: 16202778
    [No Abstract]   [Full Text] [Related]  

  • 11. Newborn bloodspot retention reinstated in Minnesota: practice expected to benefit larger newborn screening studies, public health, disease research.
    Am J Med Genet A; 2014 Sep; 164A(9):viii-ix. PubMed ID: 25125344
    [No Abstract]   [Full Text] [Related]  

  • 12. Return of Results from Research Using Newborn Screening Dried Blood Samples.
    Lewis MH; Goldenberg AJ
    J Law Med Ethics; 2015; 43(3):559-68. PubMed ID: 26479566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of informed consent for a cystic fibrosis newborn screening program in France: low refusal rates for optional testing.
    Dhondt JL
    J Pediatr; 2005 Sep; 147(3 Suppl):S106-8. PubMed ID: 16202772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citizens' values regarding research with stored samples from newborn screening in Canada.
    Bombard Y; Miller FA; Hayeems RZ; Carroll JC; Avard D; Wilson BJ; Little J; Bytautas JP; Allanson J; Axler R; Giguere Y; Chakraborty P
    Pediatrics; 2012 Feb; 129(2):239-47. PubMed ID: 22250019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Assessment of a Shortened Consent Form for the Storage and Research Use of Residual Newborn Screening Blood Spots.
    Rothwell E; Goldenberg A; Johnson E; Riches N; Tarini B; Botkin JR
    J Empir Res Hum Res Ethics; 2017 Dec; 12(5):335-342. PubMed ID: 29073807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parents' experiences of sharing neonatal information and decisions: consent, cost and risk.
    Alderson P; Hawthorne J; Killen M
    Soc Sci Med; 2006 Mar; 62(6):1319-29. PubMed ID: 16213077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention and research use of residual newborn screening bloodspots.
    Botkin JR; Goldenberg AJ; Rothwell E; Anderson RA; Lewis MH
    Pediatrics; 2013 Jan; 131(1):120-7. PubMed ID: 23209103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Policy issues and stakeholder concerns regarding the storage and use of residual newborn dried blood samples for research.
    Rothwell E; Anderson R; Botkin J
    Policy Polit Nurs Pract; 2010 Feb; 11(1):5-12. PubMed ID: 20457727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Informed choice for newborn blood spot screening in the United Kingdom: a survey of parental perceptions.
    Nicholls SG; Southern KW
    Pediatrics; 2012 Dec; 130(6):e1527-33. PubMed ID: 23147970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Information and consent for newborn screening: practices and attitudes of service providers.
    Kerruish NJ; Webster D; Dickson N
    J Med Ethics; 2008 Sep; 34(9):648-52. PubMed ID: 18757632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.